MedCity News
OCTOBER 31, 2022
A transformation is underway in medical coding as automation permeates revenue cycle management, raising questions such as: How will automation affect how medical coders work? How advanced is coding automation currently? What kind of skill sets will be needed for these new types of coding?
Pharmaceutical Technology
OCTOBER 31, 2022
After decades of setbacks, the respiratory syncytial virus (RSV) vaccine field has bounced back with positive Phase III trial results in older adults. There are currently five players in the race, with vaccines in Phase III of development from GlaxoSmithKline (GSK) , Pfizer , Johnson & Johnson , Moderna and Bavarian Nordic. However, recent data from GSK’s sub-unit vaccine, GSK-3844766A, have pushed the candidate to the top, with the highest efficacy demonstrated in a pivotal trial to date.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 31, 2022
Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.
Healthcare Success
OCTOBER 31, 2022
Google Trends is a powerful but underutilized tool that helps healthcare marketers. Conduct search engine optimization (SEO) research, Identify current trends, Find out what people are interested in, And build better, more relevant campaigns. It also allows marketers to analyze search term popularity over time, explore related keywords, and compare how search terms vary across different geographical areas.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
OCTOBER 31, 2022
While the top-level view of the growth in the hospice industry at 20-plus percent is impressive, it’s worth looking at a few prominent examples to gain further insight into this accelerating trend.
Medgadget
OCTOBER 31, 2022
Researchers at MIT have developed a sensor system that can provide data on how well a face mask fits to a wearer’s face. The protection offered by a mask is largely dependent on how well it fits the face, but at present most face masks are one-size-fits-all and most wearers are largely unaware if their mask is providing maximal protection. This latest technology is an adhesive polymer frame containing a range of sensors.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
OCTOBER 31, 2022
Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. Over three days and across 12 stages within multiple biomes, over 130 sessions will take place, including 300 speakers. The singular purpose of them all? ‘A Vision for Britain.’.
MedCity News
OCTOBER 31, 2022
People who experience food insecurity also experience health issues such as obesity, diabetes, depression, high levels of stress, anxiety, and long-term consequences due to less access and affordability to nutritious food.
MedReps
OCTOBER 31, 2022
There are many different types of medical sales out there and devices are just one of the niches you may find yourself representing. Unlike other forms of medical specialties, like pharmaceuticals, you’ll need to be prepared to do a bit more than just present literature about the products. Medical devices can include a wide range of products, most of which your customers will need to spend some time with before you make that sale.
MedCity News
OCTOBER 31, 2022
The seed funding was co-led by Felicis Ventures and SemperVirens. Midi Health will use the $14 million to expand beyond California, form new partnerships and train and hire additional staff.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTech
OCTOBER 31, 2022
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.
PharmaVoice
OCTOBER 31, 2022
The Inflation Reduction Act helps support American families by lowering prescription drug prices and reducing overall healthcare costs.
European Pharmaceutical Review
OCTOBER 31, 2022
AbbVie has announced that the European Medicines Agency (EMA) has validated its Marketing Authorisation Application (MAA) for epcoritamab, a bispecific antibody (bsAb) for adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after more than two lines of systemic therapy, offering patients a potential new therapy option. Additionally, Danish biotech Genmab has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for epcoritamab for ad
MedCity News
OCTOBER 31, 2022
The value-based partnership is for Humana Medicare Advantage HMO and PPO plan members with chronic kidney disease, who are living in Tennessee, Alabama, Mississippi and Louisiana. These members can access Monogram’s specialized care resources, such as in-home primary and specialty care visits, medication management, dialysis and social services.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
European Pharmaceutical Review
OCTOBER 31, 2022
The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects. Risks of amfepramones. The committee observed that patients continued taking the medicines for more than three months, much longer than the recommended four to six weeks.
PharmaVoice
OCTOBER 31, 2022
How new tools are helping companies find and keep cancer patients in clinical studies.
European Pharmaceutical Review
OCTOBER 31, 2022
EcoAct’s 12th annual Corporate Climate Reporting Performance Report revealed the biopharmaceutical sector was above average in achieving emission-related goals, with GSK being FTSE 100’s best performer. Yet half (52 percent) of FTSE 100 companies were found not to have reduced emissions aligned to a 1.5°C trajectory. Some unfortunately, increased their emissions.
PharmaTimes
OCTOBER 31, 2022
Information from 17 existing studies was reviewed, involving 91 million people
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
OCTOBER 31, 2022
The osteoarthritis (OA) market was valued at $2.5 billion in the 7MM (seven major markets) in 2021, and is expected to increase to $3.8 billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. Major drivers of growth in the OA market over the forecast period include the launch of new biologic therapies as well as the launch of drugs with novel mechanisms of action (MOAs) and disease-modifying effects.
pharmaphorum
OCTOBER 31, 2022
When Michael Sen took over as chief executive of Fresenius at the start of this month, he knew he was facing some big challenges. Now, a few weeks into the job, he is seeking a “reset” of the debt-laden healthcare group, amid speculation it may be under pressure to break up. Sen (pictured above) was barely in the new role before activist hedge fund Elliott Investment Management took what is reported to be a “substantial” stake in the group a couple of weeks ago, with mark
Pharmaceutical Technology
OCTOBER 31, 2022
The US Food and Drug Administration (FDA) has accepted Outlook Therapeutics’ Biologics License Application (BLA) filing for ONS-5010 / LYTENAVA (bevacizumab-vikg) to treat wet age-related macular degeneration (wet AMD). The investigational ophthalmic formulation of bevacizumab, ONS-5010 is currently being developed as an intravitreal injection to treat wet AMD and other retinal diseases.
Copyright Clearance Center
OCTOBER 31, 2022
The post Making College (Textbooks) Affordable appeared first on Copyright Clearance Center.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Clarify Health
OCTOBER 31, 2022
Clarify Health was recently recognized in Comparably’s Happiest Employees 2022 List under the “Small/Medium Sized Companies” category. The Comparably Awards stem from sentiment ratings provided by employees who anonymously rated their employers on Comparably.com during a 12-month period (September 14, 2021, through September 14, 2022) on topics that contribute to overall happiness at work.
Pharmaceutical Technology
OCTOBER 31, 2022
The European Medicines Agency (EMA) has validated AbbVie ’s marketing authorization application (MAA) for epcoritamab (DuoBody-CD3xCD20) to treat relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in adult patients following two or more lines of systemic therapy. Simultaneously, Genmab has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for the investigational subcutaneous IgG1-bispecific antibody to treat R/R large B-cell lymphoma (LBCL)
Clarify Health
OCTOBER 31, 2022
Clarify Health was recently recognized in Comparably’s Happiest Employees 2022 List under the “Small/Medium Sized Companies” category. The Comparably Awards stem from sentiment ratings provided by employees who anonymously rated their employers on Comparably.com during a 12-month period (September 14, 2021, through September 14, 2022) on topics that contribute to overall happiness at work.
pharmaphorum
OCTOBER 31, 2022
Shares in French biotech Inventiva were on the slide this morning after AbbVie revealed that it had decided to abandon development of cedirogant, their drug candidate for autoimmune diseases including psoriasis. The decision to drop the oral ROR gamma inverse agonist – also known as ABBV-157 – came after analysis of a recently concluded nonclinical toxicology study, according to an Inventiva statement, in which the company said it does not expect the move to have any impact on its cash position.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Happy Living Medical Sales
OCTOBER 31, 2022
Home medical equipment can help people to maintain their independence while staying safe at home. There are many different types of medical equipment that are designed to help people manage mobility and enhance their safety. Here are three common types of medical equipment found in homes. 1. Bathroom Safety Equipment. One of the most common types of. home medical equipment. is bathroom safety equipment.
pharmaphorum
OCTOBER 31, 2022
Forecasting is essential in providing clarity on decision making about the future, but poor-quality forecasts can result in decisions which are commercially damaging to organisations. Having good forecast models is critical for effective and efficient decision-making. It’s widely accepted that there is no such thing as 100% accuracy in long range forecasting, but often inaccuracies are driven by a poorly built model which lacks transparency and doesn’t follow best practice, combined with poor as
Pharmacy Times
OCTOBER 31, 2022
Purpose-built assisted reality solutions help streamline processes and maintain regulatory compliance from the laboratory to the factory floor.
PharmaTimes
OCTOBER 31, 2022
A final decision for daprodustat by the FDA is expected by 1 February 2023
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
142 
Let's personalize your content